Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Boomskidon Apr 13, 2023 11:13am
185 Views
Post# 35393014

Tailwinds Research - Daniel Carlson's "Good News" Post

Tailwinds Research - Daniel Carlson's "Good News" Post
Yeah, Tailwinds, Daniel Carlson, was a real gem of a promoter for Bioasis, paid well, delivering little. I have all of your paid promotions, Danny Boy, weak by all standards. I was never prepared to sell my soul as a promoter as you were. When you were let go by Bioasis for ineffectiveness you went quite weird. 
 
Daniel Carlson is the owner of TW Research Group LLC, formerly known as Tailwind or something. He uses his own company name as his Stockhouse alias. He started with a partner who promptly dumped him. I have his former partner’s name.
 
I won't apologize for anything. I have posted my concerns about Bioasis since 2011, when I first heard of and invested in Bioasis. It's an ethical decision that you cannot contemplate, Danny, to try to fully understand the compelling possibilities of a technology like Transcend/xB3, to write with knowledge about its possibilities and yet feel the need to also write about the inadequacies of managements who squandered 15 years avoiding the development of xB3 through preclinical and clinical programs.
 
I lost over a quarter of a million dollars in revenue and Bioasis stock - time and money that I expended to try to help Bioasis make something of itself. The underpinning of all those efforts was xB3, not Bioasis and not its management. There are many who lost a lot more than I, and its heartbreaking.
 
You, Danny, like many others, find trolling to be fun, a sport to idle away your unproductive hours. Make no mistake, I do not roll over. 
 
jd
<< Previous
Bullboard Posts
Next >>